Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant HBV S/L-HBsAg/L glycoprotein Protein, C-S Tag (EVV03001)

Applications:ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system:Mammalian Cells
Accession:Q9E6S4
Protein length:Met175-Ile400
Overview

Catalog No.

EVV03001

Expression system

Mammalian Cells

Species

Hepatitis B virus

Protein length

Met175-Ile400

Predicted molecular weight

29.41 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q9E6S4

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Large envelope protein, L glycoprotein, L-HBsAg, LHB, Large S protein, Large surface protein, Major surface antigen, S

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Hepatitis B virus S/L-HBsAg/L glycoprotein
  • Bioactivity
    Detects Exbivirumab in indirect ELISAs.
  • Bioactivity
    Detects Libivirumab in indirect ELISAs.
  • Bioactivity
    Detects HBV HBsAg antibody in indirect ELISAs.
  • Bioactivity
    Detects HBV HBsAg antibody in indirect ELISAs.
References

O-glycosylated HBsAg peptide can induce specific antibody neutralizing HBV infection. PMID: 34582939

Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension. PMID: 35973578

Skin immunization with third-generation hepatitis B surface antigen using microneedles. PMID: 31466705

Phosphorylation of the Hepatitis B Virus Large Envelope Protein. PMID: 35282608

Characterization of HBV surface antigen isoforms in the natural history and treatment of HBV infection. PMID: 37026760

HBsAg loading on dendritic cells in patients with chronic hepatitis B: expressions of phenotypic molecules. PMID: 16481284

Micropropagation of transgenic lettuce containing HBsAg as a method of mass-scale production of standardised plant material for biofarming purposes. PMID: 27655251

Immunogenicity of parenterally delivered plant-derived small and medium surface antigens of hepatitis B virus. PMID: 26905723

Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation. PMID: 22246107

A sensitive immunoassay for determination of hepatitis B surface antigen and antibody in human serum using capillary electrophoresis with chemiluminescence detection. PMID: 17689153

Role of hepatitis B virus genotype D & its mutants in occult hepatitis B infection. PMID: 24135177

Adsorption and penetration of hepatitis B virus in a nonpermissive cell line. PMID: 8184545

[Use of baculovector for the expression of HBsAg gene in insect cells]. PMID: 2800542

Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens. PMID: 12469306

Hepatitis B virus peptide inhibitors: solution structures and interactions with the viral capsid. PMID: 26100394

[The relationship between serum HBV pgRNA and antigen status in patients with chronic hepatitis B after long-term nucleotide analogues treatment]. PMID: 34517458

Transforming growth factor β as a possible independent factor in chronic hepatitis B. PMID: 33871695

Successful treatment of infantile hepatitis B with lamivudine: A case report. PMID: 34002156

A cellular protein which binds hepatitis B virus but not hepatitis B surface antigen. PMID: 10091999

Two distinct segments of the hepatitis B virus surface antigen contribute synergistically to its association with the viral core particles. PMID: 10024452

Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. PMID: 17020942

Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection. PMID: 9843489

Incidence of hepatitis B virus infection in young Chinese blood donors born after mandatory implementation of neonatal hepatitis B vaccination nationwide. PMID: 29624818

Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library. PMID: 12436474

Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients. PMID: 37069959

[HBsAg and anti-HBs in thalassemia non-transfused patients (and in their relatives)]. PMID: 728269

Comparison of direct and indirect two-site binding enzyme immunoassay. PMID: 7046998

[HBsAg in the prevention of post-transfusion hepatitis. General notes and data on the incidence in Umbria]. PMID: 593604

[A case of hepatitis B virus carrier complicated with nephrotic syndrome]. PMID: 10998920

Datasheet
$ 480
Product specifications
100 μg 480 1 mg 2880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant HBV S/L-HBsAg/L glycoprotein Protein, C-S Tag [EVV03001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only